128 related articles for article (PubMed ID: 7400342)
1. Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X.
Erskine JG; Walker ID; Davidson JF
J Clin Pathol; 1980 May; 33(5):445-8. PubMed ID: 7400342
[TBL] [Abstract][Full Text] [Related]
2. Maintenance control of oral anticoagulant therapy by an automated chromogenic substrate assay of factor X.
Erskine JG; Walker ID; Davidson JF
Clin Lab Haematol; 1982; 4(2):179-86. PubMed ID: 7116798
[TBL] [Abstract][Full Text] [Related]
3. Further evaluation of an automated amidolytic factor X assay in monitoring anti-vitamin K treatment.
van Wijk EM; Kahlé LH; Jeletich A; ten Cate JW
Scand J Haematol; 1982 Aug; 29(2):105-14. PubMed ID: 6813960
[TBL] [Abstract][Full Text] [Related]
4. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
[TBL] [Abstract][Full Text] [Related]
5. Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.
van Wijk EM; Kahlé LH; ten Cate JW
Clin Chem; 1980 Jun; 26(7):885-90. PubMed ID: 7379310
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.
Latallo ZS; Thomson JM; Poller L
Br J Haematol; 1981 Feb; 47(2):307-18. PubMed ID: 7470395
[TBL] [Abstract][Full Text] [Related]
7. Control of anticoagulant therapy with a chromogenic substrate.
Kirchhof BR; Muller AD; Vermeer C; Hemker HC
Haemostasis; 1979; 8(1):1-7. PubMed ID: 456941
[TBL] [Abstract][Full Text] [Related]
8. Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.
Girolami A; Saggin L; Gazzetta R; Saltarin P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):610-6. PubMed ID: 6170557
[TBL] [Abstract][Full Text] [Related]
9. A simplified amidolytic factor X assay for monitoring of oral anticoagulant therapy.
Cullmann W; Dick W; Müller N
Clin Chim Acta; 1983 Feb; 127(3):391-5. PubMed ID: 6839493
[No Abstract] [Full Text] [Related]
10. The application of an automated amidolytic factor X assay in oral anticoagulant treatment.
van Wijk EM; Jeletich A; ten Cate JW
Acta Chir Scand Suppl; 1982; 509():117-22. PubMed ID: 6962614
[No Abstract] [Full Text] [Related]
11. [Monitoring anticoagulant treatment with the KEM-O-MAT 2HP autoanalyzer].
Laharrague P; Leleu T; Poignot JL; Cambus JP; Biermé R
Nouv Rev Fr Hematol (1978); 1983; 25(2):107-12. PubMed ID: 6866753
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
McGlasson DL; Romick BG; Rubal BJ
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
[TBL] [Abstract][Full Text] [Related]
13. [Blood coagulation monitoring in oral anticoagulant therapy using chromogenic substances].
Pindur G; Seifried E; Joos A; Rasche H
Med Lab (Stuttg); 1981; 34(3):88-91. PubMed ID: 7231353
[No Abstract] [Full Text] [Related]
14. A chromogenic assay of prothrombin compared with coagulation tests during anticoagulant therapy and liver disease.
Tripodi A; Di Santo C; Mannucci PM
Ric Clin Lab; 1981; 11(3):215-22. PubMed ID: 7291868
[TBL] [Abstract][Full Text] [Related]
15. A multicenter study on amidolytic factor X evaluation in oral anticoagulant therapy.
Berthier AM; Pommereuil M; Scarabin PY; Conard J
Thromb Haemost; 1985 Jun; 53(3):433-6. PubMed ID: 4049314
[TBL] [Abstract][Full Text] [Related]
16. An assessment of an amidolytic assay for factor VII in the laboratory control of oral anticoagulants.
Poller L; Thomson JM; Bodzenta A; Easton AC; Latallo ZS; Chmielewska J
Br J Haematol; 1981 Sep; 49(1):69-75. PubMed ID: 7272230
[TBL] [Abstract][Full Text] [Related]
17. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
Chmielewska J; Latallo ZS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulant control with a chromogenic substrate: calibration, precision and cost.
Famodu AA; Ingram GI
Clin Lab Haematol; 1982; 4(1):27-39. PubMed ID: 7067373
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a new chromogenic substrate assay for the measurement of the prothrombin time.
van Wersch JW
Scand J Clin Lab Invest; 1993 Oct; 53(6):563-8. PubMed ID: 8266001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
